Stem Cell Research Funded by StemLife Berhad Yields Potential for Stem Cells to Form new Bone
News Nov 12, 2007
Research on stem cell interaction with new biomaterial has yielded three successful publications in international scientific journals by National University of Singapore and Nanoscience and Nanotechnology Initiative (NUSNNI) and StemLife Berhad. Support and funding from StemLife Berhad (StemLife), enabled the study of the interaction of novel nanofibers with bone-forming stem cells.
Based on the first presentation by the Chief Medical Officer of StemLife, Professor Dr. Aw Tar Choon shows how stem cell technology can be applied as a treatment for muscles and bones. These findings, plus other data obtained from the stem cell expansion project, prove that there is a big potential for the overall success of these research projects. "We hope that these advances in the understanding of biomaterial interaction with stem cells will lead to a revolution in orthopedic science in the future," he said.
The second presentation entitled "Nanotechnology in Healthcare", by Professor Seeram Ramakrishna, Dean of Engineering, National University of Singapore (NUS).
Professor Seeram Ramakrishna, explained the use of stem cells and two naturally occurring bone substances, collagen and hydroxyapatite that were successfully used in producing a new substance - that can mimic the action and function of natural bone substances - providing support and strength to the damaged bone when used to replace the inner core.
Prof. Seeram said that this new development "holds great potential for the construction of a new biomaterial that provides for the mineralization of osteoblasts (bone-forming stem cells) and hence the ability to regenerate new bone tissue."
According to the Journal of American Medical Association, the United Nations has declared the years 2000-2010 the "Bone and Joint Decade" to draw attention to the increasing impact orthopedic conditions will have on world health as life expectancy increases and to the potential for eliminating these problems through current and future research advances.
The management and medical panel from StemLife believe that people should be educated and informed on the numerous possibilities that stem cell technology may provide in the future.
Many scientists and clinicians have been seeking ways to treat the world's major illnesses. Stem cell research harnessing the body's own naturally occurring stem cells has begun to show some promising results and possibilities that a treatment for some of these disorders may be within reach.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019